MELENOR

Medicinal product

(Invented) name

MELENOR

Active substance (s)

Natrio rizedronatas

Strength

35 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M05BA07, Risedronic acid

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2011-10-25

Date of renewal

2016-10-31

Documents

2672 MELENOR 35mg tab PCS PL 2021_04_05.docx

2672 Pakuotės lapelis 2021_04_05.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/2145/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Natrio rizedronatas	35 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
43438	57210	1057210	lizdinė plokštelė	N4		Receptinis	LT/1/11/2672/001	Netiekiama	-	-	No	-	-
49316	63185	1063185	lizdinė plokštelė	N12		Receptinis	LT/1/11/2672/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-12-31	Išregistruotas
2016-10-31	Perregistruotas
2011-10-25	Registruotas